Entecavir vs Tenofovir in Hepatocellular Carcinoma Prevention in Chronic Hepatitis B Infection: A Systematic Review and Meta-Analysis

Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are recommended as first-line therapies for chronic hepatitis B (CHB) infection. Although both drugs reduce hepatocellular carcinoma (HCC) risk, their comparative effectiveness remains controversial. We aimed to determine whether TDF is superio...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Ka Shing, Mak, Lung Yi, Liu, Sze Hang, Cheng, Ho Ming, Seto, Wai Kay, Yuen, Man Fung, Lai, Ching Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544163/
https://www.ncbi.nlm.nih.gov/pubmed/33031195
http://dx.doi.org/10.14309/ctg.0000000000000236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544163/
https://www.ncbi.nlm.nih.gov/pubmed/33031195
http://dx.doi.org/10.14309/ctg.0000000000000236

Ejemplares similares